_version_ 1866913957505138688
author Chen, Qingyu
Keenan, Tiarnan D L
Agron, Elvira
Allot, Alexis
Guan, Emily
Duong, Bryant
Elsawy, Amr
Hou, Benjamin
Xue, Cancan
Bhandari, Sanjeeb
Broadhead, Geoffrey
Cousineau-Krieger, Chantal
Davis, Ellen
Gensheimer, William G
Grasic, David
Gupta, Seema
Haddock, Luis
Konstantinou, Eleni
Lamba, Tania
Maiberger, Michele
Mantopoulos, Dimosthenis
Mehta, Mitul C
Nahri, Ayman G
AL-Nawaflh, Mutaz
Oshinsky, Arnold
Powell, Brittany E
Purt, Boonkit
Shin, Soo
Stiefel, Hillary
Thavikulwat, Alisa T
Wroblewski, Keith James
Chung, Tham Yih
Cheung, Chui Ming Gemmy
Cheng, Ching-Yu
Chew, Emily Y
Hribar, Michelle R.
Chiang, Michael F.
Lu, Zhiyong
author_facet Chen, Qingyu
Keenan, Tiarnan D L
Agron, Elvira
Allot, Alexis
Guan, Emily
Duong, Bryant
Elsawy, Amr
Hou, Benjamin
Xue, Cancan
Bhandari, Sanjeeb
Broadhead, Geoffrey
Cousineau-Krieger, Chantal
Davis, Ellen
Gensheimer, William G
Grasic, David
Gupta, Seema
Haddock, Luis
Konstantinou, Eleni
Lamba, Tania
Maiberger, Michele
Mantopoulos, Dimosthenis
Mehta, Mitul C
Nahri, Ayman G
AL-Nawaflh, Mutaz
Oshinsky, Arnold
Powell, Brittany E
Purt, Boonkit
Shin, Soo
Stiefel, Hillary
Thavikulwat, Alisa T
Wroblewski, Keith James
Chung, Tham Yih
Cheung, Chui Ming Gemmy
Cheng, Ching-Yu
Chew, Emily Y
Hribar, Michelle R.
Chiang, Michael F.
Lu, Zhiyong
contents Timely disease diagnosis is challenging due to increasing disease burdens and limited clinician availability. AI shows promise in diagnosis accuracy but faces real-world application issues due to insufficient validation in clinical workflows and diverse populations. This study addresses gaps in medical AI downstream accountability through a case study on age-related macular degeneration (AMD) diagnosis and severity classification. We designed and implemented an AI-assisted diagnostic workflow for AMD, comparing diagnostic performance with and without AI assistance among 24 clinicians from 12 institutions with real patient data sampled from the Age-Related Eye Disease Study (AREDS). Additionally, we demonstrated continual enhancement of an existing AI model by incorporating approximately 40,000 additional medical images (named AREDS2 dataset). The improved model was then systematically evaluated using both AREDS and AREDS2 test sets, as well as an external test set from Singapore. AI assistance markedly enhanced diagnostic accuracy and classification for 23 out of 24 clinicians, with the average F1-score increasing by 20% from 37.71 (Manual) to 45.52 (Manual + AI) (P-value < 0.0001), achieving an improvement of over 50% in some cases. In terms of efficiency, AI assistance reduced diagnostic times for 17 out of the 19 clinicians tracked, with time savings of up to 40%. Furthermore, a model equipped with continual learning showed robust performance across three independent datasets, recording a 29% increase in accuracy, and elevating the F1-score from 42 to 54 in the Singapore population.
format Preprint
id arxiv_https___arxiv_org_abs_2409_15087
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle AI Workflow, External Validation, and Development in Eye Disease Diagnosis
Chen, Qingyu
Keenan, Tiarnan D L
Agron, Elvira
Allot, Alexis
Guan, Emily
Duong, Bryant
Elsawy, Amr
Hou, Benjamin
Xue, Cancan
Bhandari, Sanjeeb
Broadhead, Geoffrey
Cousineau-Krieger, Chantal
Davis, Ellen
Gensheimer, William G
Grasic, David
Gupta, Seema
Haddock, Luis
Konstantinou, Eleni
Lamba, Tania
Maiberger, Michele
Mantopoulos, Dimosthenis
Mehta, Mitul C
Nahri, Ayman G
AL-Nawaflh, Mutaz
Oshinsky, Arnold
Powell, Brittany E
Purt, Boonkit
Shin, Soo
Stiefel, Hillary
Thavikulwat, Alisa T
Wroblewski, Keith James
Chung, Tham Yih
Cheung, Chui Ming Gemmy
Cheng, Ching-Yu
Chew, Emily Y
Hribar, Michelle R.
Chiang, Michael F.
Lu, Zhiyong
Image and Video Processing
Computer Vision and Pattern Recognition
Machine Learning
Timely disease diagnosis is challenging due to increasing disease burdens and limited clinician availability. AI shows promise in diagnosis accuracy but faces real-world application issues due to insufficient validation in clinical workflows and diverse populations. This study addresses gaps in medical AI downstream accountability through a case study on age-related macular degeneration (AMD) diagnosis and severity classification. We designed and implemented an AI-assisted diagnostic workflow for AMD, comparing diagnostic performance with and without AI assistance among 24 clinicians from 12 institutions with real patient data sampled from the Age-Related Eye Disease Study (AREDS). Additionally, we demonstrated continual enhancement of an existing AI model by incorporating approximately 40,000 additional medical images (named AREDS2 dataset). The improved model was then systematically evaluated using both AREDS and AREDS2 test sets, as well as an external test set from Singapore. AI assistance markedly enhanced diagnostic accuracy and classification for 23 out of 24 clinicians, with the average F1-score increasing by 20% from 37.71 (Manual) to 45.52 (Manual + AI) (P-value < 0.0001), achieving an improvement of over 50% in some cases. In terms of efficiency, AI assistance reduced diagnostic times for 17 out of the 19 clinicians tracked, with time savings of up to 40%. Furthermore, a model equipped with continual learning showed robust performance across three independent datasets, recording a 29% increase in accuracy, and elevating the F1-score from 42 to 54 in the Singapore population.
title AI Workflow, External Validation, and Development in Eye Disease Diagnosis
topic Image and Video Processing
Computer Vision and Pattern Recognition
Machine Learning
url https://arxiv.org/abs/2409.15087